Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Sweetenham

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Experimental Hematology|December 1, 1995
A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantationR J Smith, J W Sweetenham
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Adult lymphoblastic lymphoma: high incidence of central nervous system relapse in patients treated with the Stanford University protocolJ W Sweetenham, G M Mead, J M Whitehouse
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphomaJ W Sweetenham, G M Mead, J M Whitehouse
British Journal of Cancer|September 1, 1990
Urinary epidermal growth factor (hEGF) levels in patients with carcinomas of the breast, colon and rectumJ W Sweetenham, D E Davies, S Warnes, et al.
Experimental Hematology|November 1, 1994
Immuno-, lectin-, and enzyme-histochemical characterization of human bone marrow endotheliumL C Masek, J W Sweetenham, J M Whitehouse, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphomaJ W Sweetenham, J J McKendrick, G M Mead, et al.
Cancer|June 15, 1988
Involvement of the gastrointestinal tract by metastases from germ cell tumors of the testisJ W Sweetenham, J M Whitehouse, C J Williams, et al.
British Medical Journal (Clinical Research Ed.)|November 29, 1986
Treating ovarian cancerJ W Sweetenham, G M Mead, J M Whitehouse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma--outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow TransplantationJ W Sweetenham, R Pearce, G Taghipour, et al.
Journal of Hematotherapy & Stem Cell Research|May 17, 2000
Automated immature reticulocyte counts are early markers of engraftment following autologous PBSC transplantation in patients with lymphomaP George, R M Wyre, S J Bruty, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Experimental Hematology|December 1, 1995
A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantationR J Smith, J W Sweetenham
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Adult lymphoblastic lymphoma: high incidence of central nervous system relapse in patients treated with the Stanford University protocolJ W Sweetenham, G M Mead, J M Whitehouse
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphomaJ W Sweetenham, G M Mead, J M Whitehouse
British Journal of Cancer|September 1, 1990
Urinary epidermal growth factor (hEGF) levels in patients with carcinomas of the breast, colon and rectumJ W Sweetenham, D E Davies, S Warnes, et al.
Experimental Hematology|November 1, 1994
Immuno-, lectin-, and enzyme-histochemical characterization of human bone marrow endotheliumL C Masek, J W Sweetenham, J M Whitehouse, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphomaJ W Sweetenham, J J McKendrick, G M Mead, et al.
Cancer|June 15, 1988
Involvement of the gastrointestinal tract by metastases from germ cell tumors of the testisJ W Sweetenham, J M Whitehouse, C J Williams, et al.
British Medical Journal (Clinical Research Ed.)|November 29, 1986
Treating ovarian cancerJ W Sweetenham, G M Mead, J M Whitehouse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma--outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow TransplantationJ W Sweetenham, R Pearce, G Taghipour, et al.
Journal of Hematotherapy & Stem Cell Research|May 17, 2000
Automated immature reticulocyte counts are early markers of engraftment following autologous PBSC transplantation in patients with lymphomaP George, R M Wyre, S J Bruty, et al.
Pageof 5